MaureenDMayesMD

Rheumatology • Houston, TX

Scleroderma & Related

Professor of Medicine, University Tex Houston

Join to view full profile

Dr. Mayes is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Mayes' full profile

Already have an account?

Office
6410 Fannin St
Ste 600
Houston, TX 77030
Phone+1 832-325-7191

Fax+1 713-512-2246

Education & Training

Cleveland Clinic FoundationFellowship, Rheumatology, 1980 - 1980
Cleveland Clinic FoundationResidency, Internal Medicine, 1978 - 1979
Cleveland Clinic FoundationResidency, Internal Medicine, 1977 - 1977
Eastern Virginia Medical SchoolClass of 1976

Certifications & Licensure

TX State Medical License 2002 - 2026
MI State Medical License 1985 - 2004
VA State Medical License 1977 - 2004
WV State Medical License 1981 - 1985
OH State Medical License 1977 - 1982
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2002-2014, 2017-2020
Top Doctors:SE Texas Castle Connolly, 2013
Super Doctor SuperDoctors.com
Fellow (FACR) American College of Rheumatology
Join now to see all

Clinical Trials

Scleroderma Registry Start of enrollment: 2000 Sep 01
Completed
Efficacy and Safety of Oral Bosentan on Healing/Prevention of Digital (Finger) Ulcers in Patients With Scleroderma
COMPLETED
PHASE3
Scleroderma: Cyclophosphamide or Transplantation Start of enrollment: 2005 Jun 01
Completed
Phase 2, Phase 3
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients Start of enrollment: 2005 Feb 01
Completed
SCOT Scleroderma Treatment Alternative Registry (STAR Registry) Start of enrollment: 2005 Jun 01
Completed
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH) Start of enrollment: 2011 Jun 24
Completed
Phase 2
Scleroderma Treatment With Autologous Transplant (STAT) Study Start of enrollment: 2011 Sep 15
COMPLETED
PHASE2
Safety and Tolerability of Pirfenidone in Participants With Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD) (LOTUSS) Start of enrollment: 2013 Oct 01
Completed
Phase 2
Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension RANGER Start of enrollment: 2017 Apr 18
Terminated
Phase 3
Platform Clinical Study for Conquering Scleroderma Start of enrollment: 2024 Apr 15
RECRUITING
PHASE2
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

Trajectories of forced vital capacity in patients with systemic sclerosis-associated interstitial lung disease.
Oliver Distler, Madelon C Vonk, Arata Azuma, Maureen D Mayes, Dinesh Khanna
Arthritis Research & Therapy. 2025-03-21
Continued nintedanib in patients with systemic sclerosis-associated interstitial lung disease: 3-year data from SENSCIS-ON.
Yannick Allanore, Madelon C Vonk, Oliver Distler, Arata Azuma, Maureen D Mayes
RMD Open. 2025-02-23
Lack of association of the PLD4 SNP rs2841277 with systemic sclerosis in a European American population.
Yunqing Ma, Maureen D Mayes, Xinjian Guo, Shervin Assassi, Xiaodong Zhou
Scientific Reports. 2024-12-28

Journal Articles

The Scleroderma Patient-Centered Intervention Network Cohort: Baseline Clinical Features and Comparison with Other Large Scleroderma Cohorts
Daniel E Furst, Robert Spiera, Maureen D Mayes, Lorinda Chung, Suzanne Kafaja, Virginia Steen, Shervin Assassi, Monique Hinchcliff, Rheumatology

Press Mentions

If Your Hands Are Always Freezing, This Might Be WhyApril 16th, 2019
Seeking Solutions to Treat SclerodermaAugust 16th, 2018

Professional Memberships

American College of Rheumatology - ACR
Fellow
American College of Radiology - ACR
Master Member